Allergan plc (NYSE: AGN) , headquartered in Dublin, Ireland, is a bold global pharmaceutical leader. Allergan specializes in the development, manufacturing and marketing of originator pharmaceuticals, medical devices, biologics, surgical products and regenerative medicine for patients worldwide.
JUVEDERM VOLBELLA with Lidocaine (2x1ml)
JUVEDERM VOLBELLA with Lidocaine 2x1ml is a hyaluronic acid-based filler formulated to treat facial wrinkles and bring more volume to the skin for a younger look.
Description of JUVEDERM VOLBELLA
JUVEDERM VOLBELLA is formulated with hyaluronic acid and lidocaine to treat wrinkles around the lips, nasal furrows, crow's feet, eye contour, forehead, eyebrows and wrinkles. It enhances eyebrows, fills in wrinkles and blurs expression lines.
Thanks to its fluid consistency, JUVEDERM VOLBELLA Lidocaine 2x1ml is evenly distributed in the skin and the presence of lidocaine makes the treatment much more comfortable, thanks to its anesthetic effect. The injection does not last more than fifteen minutes depending on the targeted area. The effects of VOLBELLA are immediately visible: the skin is plumped up, the signs of aging faded. The results are visible for up to twelve months depending on the amount of product injected.
Recommendations for use
JUVEDERM VOLBELLA with Lidocaine 2x1ml is a medical device and must be used by a professional authorized to perform injections of hyaluronic acid-based products. The injection must be done using a needle provided with the kit, in the layer of skin located between the dermis and the epidermis.
JUVEDERM VOLBELLA Lidocaine 2x1ml is not recommended for any pregnant or breastfeeding woman. The presence of a known allergic terrain or a reaction to an old treatment based on hyaluronic acid also makes it a product that is not recommended. Also avoid this treatment if you have had a deep chemical peel, dermabrasion or laser treatment in the weeks before the injection. Use is also not recommended in cases of autoimmune diseases or chronic streptococcal infections.